The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD)
Medscape Medical News, November 4, 2016
Shorter Hep C Regimens Hot Topic at the Liver Meeting
Medscape-40 minutes ago
BOSTON — Shortening the length of curative regimens for hepatitis C treatment will be one of the hot topics here at The Liver Meeting 2016.
One study likely to garner significant interest examines an investigational conjugated drug (RG-101) that, used in combination with oral direct-acting antivirals, can produce high rates of sustained responses after just 4 weeks of therapy in patients with genotypes 1 and 4 hepatitis C.
Continue Reading....
No comments:
Post a Comment